Bryostatin 1 increases 1-β-D-arabinofuranosylcytosine-induced cytochrome c release and apoptosis in human leukemia cells ectopically expressing Bcl-xL

Journal of Pharmacology and Experimental Therapeutics

Volumn 301, Issue 2, 2002, Pages 568-577

  Wang, Zhiliang ^a,b   Wang, Shujie ^a,b   Dai, Yun ^a,b   Grant, Steven ^a,b  

^a Department of Medicine ^*  (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE INHIBITOR; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; BRYOSTATIN 1; CASPASE 3; CASPASE 9; CASPASE INHIBITOR; CYTARABINE; CYTOCHROME C; INHIBITOR OF APOPTOSIS PROTEIN; OLIGOMYCIN; PHOSPHORYLASE; PROTEIN BCL XL;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSIVE ELEMENT; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME LOCALIZATION; ENZYME RELEASE; HUMAN; HUMAN CELL; LETHALITY; LEUKEMIA CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-X PROTEIN; CYTARABINE; CYTOCHROME C GROUP; DRUG INTERACTIONS; HUMANS; LACTONES; LEUKEMIA; MACROLIDES; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED;

EID: 0036225876     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.301.2.568     Document Type: Article

References (42)

1. L form cytochrome c-conducting pores in pure lipid membranes
2. Bcl-x, a Bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
3. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization
4. Structural and biochemical basis of apoptotic activation by Smac/DIABLO
5. L and Bcl-2
6. Bcl-2 family: Regulators of cell death
7. Apaf-1/cytochrome c-independent and Smac-dependent induction of apoptosis in multiple myeloma (MM) cells
8. L function upstream of the CED-3-like apoptotic proteases
9. "Loop" domain is necessary for Taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting Taxol-induced accumulation of cytochrome c and apoptosis
10. The mitochondria: Is it central to apoptosis?
11. The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant
12. Modulation of drug-induced apoptosis by interruption of the protein kinase C signal transduction pathway: A new therapeutic strategy
13. Potentiation of the activity of 1-β-D-arabinofuranosylcytosine by the macrocyclic lactone PKC activator bryostatin 1 is associated with enhanced fragmentation of mature DNA
14. Modulation of 1-[β-D-arabinofuranosyl] cytosine-induced apoptosis in human myeloid leukemia cells by staurosporine and other pharmacological inhibitors of protein kinase C
15. Modulation of protein kinase C activity and calcium-sensitive isoform expression in human myeloid leukemia cells by bryostatin 1: Relationship to differentiation and ara-C-induced apoptosis
16. L prevents this release but not tumor necrosis factor-R1/Fas death
17. L does not inhibit the function of Apaf-1
18. L interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation
19. Effect of bryostatin 1 and other activators of protein kinase C on 1-beta-D-arabinofuranosylcytosine-induced apoptosis in HL-60 human promyelocytic leukemia cells
20. Cytochrome c promotes caspase-9 activation by inducing nucleotide binding to Apaf-1
21. L inhibits ara-C-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis
22. Mitochondrial control of cell death
23. Bcl-2 family members do not inhibit apoptosis by binding the caspase activator Apaf-1
24. Disruption of the outer mitochondral membrane as a result of large amplitude swelling: The impact of irreversible permeability transition
25. Bcl-2 and the regulators of programmed cell death
26. L gene expression for remission induction is influenced by cytogenetics in adult acute myeloid leukemia
27. L can differentially block chemotherapy-induced cell death
28. Simultaneous release of adenylate kinase and cytochrome c in cell death
29. Ordering the cytochrome c-initiated caspase cascade: Hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner
30. Selective inhibition of apoptosis by TPA-induced differentiation of U937 leukemic cells
31. A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis
32. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis
33. Potentiation of 1-β-D-arabinofuranosylcytosine-mediated mitochondrial damage and apoptosis in human leukemia cells (U937) overexpressing Bcl-2 by the kinase inhibitor 7-hydroxystaurosporine (UCN-01)
34. Bcl-xL promotes the open configuration of the voltage-dependent anion channel and metabolite passage through the outer mitochondrial membrane
35. Agents that down-regulate or inhibit protein kinase C circumvent resistance to 1-β-D-arabinofuranosylcytosine-induced apoptosis in human leukemia cells that overexpress Bcl-2
36. Bryostatin 1 enhances paclitaxel-induced mitochondrial dysfunction and apoptosis in human leukemia cells (U937) ectopically expressing Bcl-xL
37. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked
38. Bcl-2 expression delays drug-induced apoptosis but does not increase clonogenic survival after drug treatment in HeLa cells
39. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death
40. Injected cytochrome c induces apoptosis
41. Target protease specificity of the viral serpin CrmA. Analysis of five caspases
42. An Apaf-1-cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9